Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

A woman with a rare ovarian tumor and hyperparathyroidism improved after surgery, highlighting the need for reporting unusual cases to understand and manage rare diseases.

The patient was satisfied with hormone therapy, and her epilepsy remained stable.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

The pituitary gland is crucial for normal mink fur cycles.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Screening for reproductive health issues like endometriosis, PCOS, and STDs is crucial for early detection and prevention.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Collaboration between doctors is key to effective infertility treatment.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Ovarian and stress hormones can change GABA A receptors through neurosteroids.

Diet changes can protect against harmful environmental effects on fetal development.